Troy A. Ignelzi, Chief Financial Officer at Karuna Therapeutics, Inc. (KRTX), sold 11,882 shares at $108.15 ($1.3M) on 2020-11-06, disclosed to the SEC on 2020-11-10.
Open-market sale of $1.3M KRTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $108.15 | 564 | $61K | 4.8% |
| 2 | $108.15 | 564 | $61K | 4.8% |
| 3 | $105.02 | 8,000 | $840K | 66.7% |
| 4 | $108.26 | 1,318 | $143K | 11.3% |
| 5 | $108.26 | 1,318 | $143K | 11.3% |
| 6 | $103.48 | 118 |
| $12K |
| 1.0% |
| Total | $106.02 avg | 11,882 | $1.3M | 100% |
| Filing → |
| KRTX | SELL | 2023-05-25 | $4.0M | — | Filing → |
| KRTX | SELL | 2023-02-23 | $1.1M | — | Filing → |
| KRTX | SELL | 2023-01-19 | $369K | — | Filing → |